In compliance with Regulation 30(6) read with Part A of Schedule III of the Listing Regulations, we wish to inform that the audio recording of earnings conference call for Analysts and Investors held on February 01, 2024, at 6.00 p.m. with respect to the Company's financial results for quarter and nine months ended December 31, 2023, is available on the company's website https://investor.thyrocare.com/financials/quarterly-financial-results/.
